Holocene Advisors’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-226,895
| Closed | -$1.98M | – | 822 |
|
|
2024
Q4 | $1.98M | Sell |
226,895
-2,462,561
| -92% | -$21.4M | 0.01% | 560 |
|
|
2024
Q3 | $52.6M | Hold |
2,689,456
| – | – | 0.21% | 136 |
|
|
2024
Q2 | $55.4M | Buy |
2,689,456
+251,993
| +10% | +$5.19M | 0.23% | 129 |
|
|
2024
Q1 | $52M | Hold |
2,437,463
| – | – | 0.19% | 145 |
|
|
2023
Q4 | $35.1M | Hold |
2,437,463
| – | – | 0.14% | 176 |
|
|
2023
Q3 | $22.2M | Hold |
2,437,463
| – | – | 0.1% | 203 |
|
|
2023
Q2 | $25.8M | Hold |
2,437,463
| – | – | 0.11% | 188 |
|
|
2023
Q1 | $29.8M | Sell |
2,437,463
-101,142
| -4% | -$1.24M | 0.15% | 169 |
|
|
2022
Q4 | $31.5M | Sell |
2,538,605
-937,500
| -27% | -$11.6M | 0.19% | 145 |
|
|
2022
Q3 | $47.5M | Buy |
3,476,105
+218,809
| +7% | +$2.99M | 0.3% | 102 |
|
|
2022
Q2 | $59.7M | Buy |
3,257,296
+14,488
| +0.4% | +$266K | 0.36% | 92 |
|
|
2022
Q1 | $52.1M | Buy |
3,242,808
+881,977
| +37% | +$14.2M | 0.27% | 120 |
|
|
2021
Q4 | $33.1M | Sell |
2,360,831
-353,593
| -13% | -$4.95M | 0.17% | 152 |
|
|
2021
Q3 | $50.8M | Buy |
2,714,424
+126,642
| +5% | +$2.37M | 0.28% | 106 |
|
|
2021
Q2 | $54M | Buy |
2,587,782
+346,430
| +15% | +$7.22M | 0.3% | 103 |
|
|
2021
Q1 | $63.4M | Buy |
2,241,352
+621,806
| +38% | +$17.6M | 0.4% | 74 |
|
|
2020
Q4 | $52.9M | Buy |
1,619,546
+355,337
| +28% | +$11.6M | 0.33% | 102 |
|
|
2020
Q3 | $38.7M | Buy |
1,264,209
+371,281
| +42% | +$11.4M | 0.29% | 98 |
|
|
2020
Q2 | $14.6M | Buy |
+892,928
| New | +$14.6M | 0.13% | 154 |
|